RT Journal Article
SR Electronic
A1 Coltrera, Francesca
T1 BEST Trial
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 5
SP 14
OP 15
DO 10.1177/1559897715583796
UL http://mdc.sagepub.com/content/15/5/14.abstract
AB Percutaneous coronary intervention with second-generation everolimus-eluting stents was inferior to coronary artery bypass graft surgery in patients with multivessel coronary artery disease in the open-label prospective randomized BEST trial. The composite primary outcome (all-cause death, myocardial infarction, target vessel revascularization) occurred more frequently in patients randomized to percutaneous coronary intervention.